References
- Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release 2004;95:627–638
- Zackrisson G, Ostling G, Skanderberg B, Anfält T. Accelerated dissolution rate analysis (ACDRA) for controlled release drugs: application to Roxiam. J Pharm Biomed Anal 1995;13:377–383
- Faisan N, Akiki J, Siepmann F, et al. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory. Int J Pharm 2006;314:89–197
- Zolnik BS, Burgess DJ. Effect of acidic pH on PLGA microsphere degradation and release. J Control Release 2007;122:338–344
- Alexis F. Factors affecting the degradation and drug-release mechanism of poly (lactic acid) and poly (lactic acid)-co-(glycolic acid). Polym Int 2005;54:36–46
- Rawata A, Stippler E, Shahb VP, Burgessa DJ. Validation of USP apparatus 4 method for microsphere in vitro release testing using Risperdal® Consta®. Int J Pharm 2011;420:198–205
- Kamberi M, Nayak S, Myo-Min K, et al. A novel accelerated in vitro release method for biodegradable coating of drug eluting stents: insight to the drug release mechanisms. Eur J Pharm Sci 2009;37:217–222
- Shen J, Burgess DJ. Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings. Int J Pharm 2012;422:341–348
- Faisant N, Siepmann J, Oury P, et al. The effect of gamma-irradiation on drug release form biodegradable microparticles: a quantitative treatment. Int J Pharm 2002;242:281–284
- Shameem M, Lee H, DeLuca PP. A short-term (accelerated release) approach to evaluate peptide release from PLGA depot formulations. AAPS Pharm Sci 1999;1:E7
- Du LN, Mei XG, Wang CY, et al. In-vitro/in-vivo studies of the biodegradable poly-(d,l-lactide-co-glycolide) microspheres of a novel luteinizing hormone-releasing hormone antagonist for prostate cancer treatment. Anti Cancer Drugs 2011;22:262–272
- Goldstein G, Scheid MP, Boyse EA, et al. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin. Science 1979;204:1309–1310
- Conti B, Panico M, Ventura CA, et al. Thymopentin loaded microsphere preparation by w/o/w emulsion technique: in vitro/ex vivo evaluation. J Microencapsul 1997;14:303–310
- Okada H. One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. Adv Drug Deliv Rev 1997;28:43–70
- Li Z, Li L, Liu Y, et al. Development of interferon alpha-2b microspheres with constant release. Int J Pharm 2011;410:48–53
- Moore JW, Flanner HH. Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm Technol 1996;20:64–74
- Lyu S, Untereker D. Degradability of polymers for implantable biomedical devices. Int J Mol Sci 2009;10:4033–4065
- Burgess DJ, Crommelin DJA, Hussain AS, Chen ML. Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report. AAPS Pharm Sci 2004;6:100–111
- Ford-Versypt AN, Pack DW, Braatz RD. Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres-a review. J Control Release 2013;10:29–37
- Araújo J, Vega E, Lopes C, et al. Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids Surf B: Biointerfaces 2009;72:48–56
- Diwan M, Park TG. Pegylation enhances protein stability during encapsulation in PLGA microspheres. J Control Release 2001;73:233–244
- Helm VJ, Müller BW. Stability of the synthetic pentapeptide thymopentin in aqueous solution: effect of pH and buffer on degradation. Int J Pharm 1991;70:29–34
- Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release 2001;73:121–136
- Zolnik BS, Leary PE, Burgess DJ. Elevated temperature accelerated release testing of PLGA microspheres. J Control Release 2006;112:293–300
- Martinez M, Rathbone M, Burgess D, Huynh M. In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting. J Control Release 2008;129:79–87